FDA approves application for AquaBounty salmon facility in Indiana
The U.S. Food and Drug Administration (FDA) has approved a supplemental New Animal Drug Application (NADA) submitted by AquaBounty Technologies to raise AquAdvantage Salmon—a product under an application previously approved in 2015—at a land-based contained facility near Albany, Ind.
Top